32 results
Thumbnail

D2.214 - Alpha-Amylase Inhibitors as Allergens in Wheat Flour Sensitivity

Thumbnail

D2.213 - Unveiling Pitaya Pollen Allergenicity: A Case Study in Occupational Allergy

Thumbnail

D2.215 - Retrospective evaluation of the outcome of 106 oral food challenges performed in 2017 to 2024

Thumbnail

D2.216 - Sensitization to legumes after an occupational allergy produced by guar gum

Thumbnail

D2.217 - A human monoclonal antibody displays promiscuous binding to multiple nsLTP allergens

Thumbnail

D2.218 - ASSESSING THE DIAGNOSTIC VALUE OF SPECIFIC IgG4 IN KOREAN ADULT SHRIMP ALLERGY BASED ON SYMPTOM PRESENCE

Thumbnail

D2.219 - An “egg-bird syndrome” in a 12-year-old male child

Thumbnail

D2.220 - NsLTPs as Allergens in Pitaya and Hemp Seeds: A Case Study

Thumbnail

D2.222 - Histamine intolerance is uncommon among Chinese patients reporting allergic reactions to shrimp

Thumbnail

D2.223 - Implementing a liberated diet in food allergy management: Practical approaches and challenges from the TINA trial

Thumbnail

D2.224 - Cross-tolerance to cashew by prophylactic sublingual immunotherapy with different tree nuts in Brown Norway rats

Thumbnail

D2.225 - Fixed-Dose Oral Immunotherapy for High-Threshold Food Allergy: Efficacy and Safety in Real-World Practice

Thumbnail

D2.226 - Optimised recovery of specific food allergens from challenging food matrices

Thumbnail

D2.228 - Changes in temperature during allergic reactions to food in human volunteers

Thumbnail

D2.229 - Hypersensitivity reactions associated with the use of food supplements containing propolis. Analysis of observations reported to the French National Agency for Food, Environmental and Occupational Health Safety (Anses)

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study